Autonomous Commercial Vehicle Global Market Analysis, Trends, Growth, Research And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Antivirals Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $143.83 billion In 2028 At A CAGR Of 8.0% :

The antivirals market size has grown strongly in recent years. It will grow from $97.72 billion in 2023 to $105.73 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to viral disease prevalence, public health concerns, patent expirations, government initiatives.

The antivirals market size is expected to see strong growth in the next few years. It will grow to $143.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to emerging viral threats, global health initiatives. Major trends in the forecast period include technological advances, telemedicine and digital health, personalized medicine.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Antivirals Market Major Segments
The antivirals market covered in this report is segmented -

1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Key Driver - Increasing Incidence OF Influenza In The Antivirals Market

The increasing incidence of influenza is anticipated to propel the growth of the antiviral market going forward. Influenza, also called flu, is a highly contagious viral respiratory infection caused by influenza viruses that affect the nose, throat, and lungs. Antivirals are used for the treatment of influenza and are designed to inhibit the replication and spread of influenza viruses within the body. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based health agency, during 2021-2022 season, there were 9 million flu illnesses, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Therefore, the increasing incidence of influenza is driving the growth of the antiviral market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=2437&type=smp

Prominent Trend - Innovative Technological Advancements In The Antivirals Market

Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus. Technological advances in the pharmaceutical sector include the development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce vaccine antigens. For instance, in October 2021, Merck & Co. Inc, a US-based pharmaceutical company and Ridgeback Biotherapeutics a US-based biotechnology company launched Oral Antiviral Molnupiravir. Oral Antiviral Molnupiravir is an antiviral medication for COVID-19. This was approved by the US Food and Drug Administration (FDA), a US-based federal agency for the treatment of mild-to-moderate COVID-19 for emergency use. This is an orally administered nucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19.

Antivirals Market Players
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antivirals Market Report Structure
3. Antivirals Market Trends And Strategies
4. Antivirals Market - Macro Economic Scenario
5. Antivirals Market Size And Growth
…..
27. Antivirals Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.